Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPA-Keloid
NCT04049552Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sirolimus in keloid (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Change in Keloid Surface Area at 6 months. Started Jan 2020; status: completed.
02
Drugs
sirolimus
03
Conditions
keloid
Beyond the preview
Go deeper on NCT04049552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049552.